Section Arrow
WST.NYSE
- West Pharmaceutical Services
Quotes are at least 15-min delayed:2026/07/06 05:38 EDT
Pre Market
Last
 370
+4.26 (+1.16%)
Bid
303.5
Ask
394
High 370 
Low 365.5 
Volume 22 
Regular Hours (Closed)
Last
 365.74
+0.74 (+0.20%)
Day High 
367.66 
Prev. Close
365 
1-M High
365.485 
Volume 
547.22K 
Bid
303.5
Ask
394
Day Low
362.8301 
Open
366.08 
1-M Low
309.88 
Market Cap 
25.79B 
Currency 美元 
P/E 48.8 
%Yield 0.24 
10-SMA 343.41 
20-SMA 334.39 
50-SMA 317.99 
52-W High 365.485 
52-W Low 206.8 
Exchange NYSE 
Valuation Estimation
EPS (Current/Estimated)
7.48/9.25
Enterprise Value
26.08B
Balance Sheet
Book Value Per Share
42.33
Cash Flow
Cash Flow Yield
0.03
Income Statement
Total Revenue
3.07B
Operating Revenue Per Share
41.42
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
MDLNMedline Inc43.19+1.46+3.50%36.51PE
Pre Market 43.1 -0.09 -0.21%
AVTRAvantor10.32+0.31+3.10%-- 
Pre Market 10.34 +0.02 +0.19%
BAXBaxter International22.65+0.96+4.43%-- 
Pre Market 22.6877 +0.0377 +0.17%
XRAYDENTSPLY SIRONA11.65+0.56+5.05%-- 
Pre Market -- -- --
COOCooper Companies (The)74.2+2.25+3.13%60.97PE
Pre Market 73.69 -0.51 -0.69%
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
West Pharmaceutical Services is based in Pennsylvania and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), nonglass containment solutions, and auto-injectors for injectable drugs, which include large-molecule biologics, peptides such as GLP-1 receptor agonists, and small-molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.